In vitro stimulation of fibroblast activity by factors generated from human monocytes activated by biomedical polymers.
Biomedical polymers used in constructing implantable artificial devices may affect host responses to the material and ultimately contribute to the success or failure of a device via mechanisms of cell-polymer interactions. Human peripheral blood monocytes (MO) cultured in the presence of several such biomedical polymers released factors that stimulated fibroblast proliferation and/or collagen synthesis. The factors that stimulated fibroblast proliferation were differentially released from monocytes cultured in the presence of Dacron, polyethylene, expanded polytetrafluoroethylene (ePTFE), polydimethylsiloxane, and polystyrene (control). Supernatants obtained from monocytes cultured in the presence of Biomer, a segmented polyetherurethane, were unable to stimulate fibroblast proliferation. However, supernatants from all cultures, including MO-Biomer cultures, were able to induce collagen production from the same target fibroblasts. These same supernatants also were shown to contain interleukin 1 (IL1) activity. Neutralization of the fibroblast stimulatory potential (FSP) activity with antibodies directed against human IL1 and human PDGF demonstrated that IL1 and not PDGF was responsible for the FSP activity. Results of this study show that by affecting macrophage activation, different biomedical polymers can affect host biocompatibility responses by altering fibroblast proliferation and function.
Miller
K M
KM
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106.
Anderson
J M
JM
D000328:Adult; D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003094:Collagen / Q000096:biosynthesis; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects; D006133:Growth Substances / Q000096:biosynthesis* / Q000097:blood / Q000494:pharmacology; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis* / Q000097:blood / Q000494:pharmacology; D008213:Lymphocyte Activation; D051379:Mice; D009000:Monocytes / Q000187:drug effects / Q000502:physiology*; D011093:Polyethylene Terephthalates / Q000494:pharmacology; D011095:Polyethylenes / Q000494:pharmacology; D011138:Polytetrafluoroethylene / Q000494:pharmacology; D011140:Polyurethanes / Q000494:pharmacology; D012833:Siloxanes / Q000494:pharmacology; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology
D001672:Biocompatible Materials; D006133:Growth Substances; D007375:Interleukin-1; D011093:Polyethylene Terephthalates; D011095:Polyethylenes; D011140:Polyurethanes; D012833:Siloxanes; C031892:biomer; D011138:Polytetrafluoroethylene; D003094:Collagen